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INTRODUCTION 
Advancements in drug delivery  strategies are taking place 
at much prompt pace than the last decade. Currently 74% 
of drugs are taken orally but not found to be as effective as 
desired because of various obstacles coming in path of oral 
drug delivery. Today transdermal drug delivery system is 
one of the most capable modes  of drug application. Drug 
delivery via skin to achieve systemic effect of drug is 
commonly referred to as transdermal drug delivery. 
Dermal application of drugs offer many advantages as 
increased patient acceptability, avoidance of 
gastrointestinal disturbances
1
, bypass of first pass hepatic 
metabolism
2
 and sustained delivery of drugs and reduced 
systemic side effects
3
. Recent attention has been sharply 
focused on microemulsions which in addit ion to aforesaid 
advantages reveal superior stability. Microemulsions 
represent versatility as novel vehicle having potential of 
increasing percutaneous delivery of both hydrophilic and 
lipophilic drugs
4
. The review exp lores microemulsions in 
relation to their use to modify penetration rate of drug 
across skin and dermal tolerability of vehicles. The 
components, composition and structure of microemulsions 
are also discussed. 
Microemulsions 
The microemulsion concept was introduced by Hoar and 
Schulman in early 1940s who created single clear phase 
solution by titrating milky emulsion with hexanol and the 
term microemulsion was coined by Schulman and 
coworkers in 1959. Microemulsions are 
thermodynamically stable, isotropically clear mixture of 
oil, water and surfactant frequently in combination with 
cosurfactant
5
. These homogenous systems have gained 
wide acceptance because of their enhanced drug 
solubilization, longer shelf life due to thermodynamic 
stability, easy format ion because of zero interfacial 
tension, ability to be sterilized by filtration, massive 
surface area
6
. 
In some respects, microemulsions can be considered as 
small scale version of emulsions i.e. droplet type 
dispersions. Such a description however lacks precision 
since there are significant differences between emulsions 
and microemulsions. In particular, in emulsions, the 
average drop size grows continuously with time so that 
phase separation ultimately occurs under gravitational 
force, i.e . they are thermodynamically unstable and their 
formation requires input of work. The drops of the 
dispersed phase are generally large (> 0.1 μm) so that they 
take a milky appearance
7
. On the other side, for 
microemulsions, once the conditions are right, spontaneous 
formation occurs they are clear or translucent in size range 
of 20-200 nm. Microemulsions are vibrant systems in 
which interface is continuously fluctuating. According to 
the structure they are divided into oil in water (o/w), water 
in oil (w/o) and bicontinuous microemulsions. In all these 
microemulsions interface is stabilized by appropriate 
combination of surfactant and cosurfactant
6,7 
. 
Role of microemulsion in skin permeation 
The skin is incredible organ of body which is competent to 
perform various vital functions. It is an effectual 
communicator between the outside environment and brain. 
Skin makes upto 12-15% of adult’s body weight. Each 
square centimeter has 6 million cells, 5000 sensory points , 
100 sweat glands and 15 sebaceous glands . The skin is 
composed primarily o f three layers: the epidermis , the 
dermis and the hypodermis
8
. 
Epidermis: It is the outermost layer of skin. It forms  
waterproof defensive wrap upon body’s surface and 
formed up of stratified squamous epithelium underly ing 
basal lamina. It contains no blood vessels and is nourished 
by diffusion from dermis and has role in regulation of 
body’s temperature. It is further divided into 5 sublayers:  
Stratum corneum, St ratum lucidum, St ratum granulosum, 
Stratum spinosum and Stratum germinativum 
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Dermis: It is the layer of skin underneath the epidermis 
that consists of connective tissue and mitigates the body 
from stress and strain. It is rig idly connected to epidermis 
by basement membrane. It contains hair fo llicles, sweat 
glands, sebaceous glands, apocrine glands, lymphatic 
vessels and blood vessels. The dermis is structurally 
segregated into two areas; a superficial area called as 
papillary region and the reticular region.  
Hypodermis:  Its rationale is to attach the skin to 
underlying bones and muscles. It consist loose connective 
tissue and elastin. 
The great hindrance for transdermal drug delivery is the 
stratum corneum that forms primary rate restrictive barrier 
to permeation of drugs across the skin. It consists of dead 
flattened cells filled with keratin that are entrenched in 
lip id matrix. The stratum corneum has been illustrated as 
hydrophilic protein bricks embedded in hydrophobic lipid  
mortar. Diffusion of drug in dermal vasculature includes 
contact of skin with dosage form from which the active 
constituent must partition, followed by diffusion of 
compound to external strata to dermis. Partit ioning is 
governed to large extent by thermodynamic activ ity of the 
drug in the vehicle and this aspect is of major importance 
in controlling the degree of penetration. It is relevant to 
note that transdermal delivery potential of microemulsions 
is dependent not only on constituents  of vehicle but also on 
internal structure of the phases. Several plausible 
mechanis ms of skin  permeation enhancement property 
have been proposed. A large amount of active principle 
can be incorporated in the formulation due to high 
solubilizing capacity that might increase thermodynamic 
activity towards the skin. The surfactant and co-surfactant 
in the microemulsion may lessen the diffusional barricade 
of stratum corneum by operating as penetration enhancers . 
The percutaneous absorption of the active agent will also 
augment due to hydration effect of stratum corneum if the 
water content in microemulsion is high enough. The 
nanosized droplets provide superior adherence to skin and 
have large surface area thereby providing high 
concentration gradient and improved active constituent 
permeat ion. The permeation rate of drug from 
microemulsion can be increased as the empathy of drug to 
internal phase in microemulsion can be easily modified to 
favor partitioning into stratum corneum using different 
internal phase, changing its portion in microemulsion
8,9
. 
If the endeavor is at providing sustained release of 
lipophilic act ive constituent then it is integrated into inner 
oil phase in o/w microemulsions so that active agent will 
partition from inner compartment to outer aqueous 
compartment and then it is released into skin.  Some 
microemulsions act as supersolvent of highly lipophilic 
compounds due to having capacity of incorporating large 
amount of it. When the aim is towards immediate 
absorption and short duration of action then w/o type can 
be formulated. The condition shall be reversed if the active 
constituent is hydrophilic. Due to presence of both 
hydrophilic and lipophilic domains, it can be suggested 
that microemulsions are able to interact with both lipid  
(nonpolar) and the protein (polar) pathway by entering 
stratum corneum v ia intercellu lar route. The drug 
dissolved in lip id domain can directly partition in lipids of 
stratum corneum thereby destabilizing its bilayer 
eventually leading to increased permeability
9
. On the other 
side hydrophilic domain hydrates the stratum corneum 
which facilitates percutaneous uptake of drug.   
Outline of theories of microemulsion formation 
Microemulsions are formed simultaneously when 
interfacial tension between oil and water is reduced close 
to zero. The formation and as well as stability of 
microemulsion can be affected by various factors such as 
nature of surfactant, molecular weight of surfactant, 
alcohol chain length, temperature etc. 
Three approaches have been used to explain  
microemulsion format ion
7
: 
(i) Interfacial or mixed film theory: It states film at the 
interface is assumed to be dual film and the type of 
microemulsion (o/w or w/o) depends on bending or 
curvature of interface. 
(ii) Solubilizat ion theory: It states that oil is solubilized by 
normal micelles and water is solubilized by reverse 
micelles. 
(iii) Thermodynamic theory: It states that free energy 
of format ion must be negative to form 
thermodynamically stable microemulsion.  
COMPONENTS OF MICROEMULS ION 
The components of microemu lsion format ion as oils and 
surfactants are largely present but due to their toxicity, 
irritancy and unclear mechanis m of act ion retards their use. 
For mild microemulsions to form, b iocompatib le, 
clin ically acceptable, non toxic components should be 
screened. Therefore greater emphasis is laid  upon use of 
generally regarded as safe (GRAS) excip ients 
Oil phase  
The selection of oil is based on the nature of the drug as 
well as the route of administration. The screened oil should 
have solubilizat ion potential for the drug. The oil 
influences the curvature and has the capability to swell the 
tail group of surfactant. Saturated and unsaturated fatty 
acids have penetration enhancing activity of their own. The 
fatty acids increase the permeability of by disrupting  
densely packed lipids and filled up in extracellular spaces 
of stratum corneum. Amongst unsaturated fatty acids, oleic 
acid is an effective skin penetration enhancer. Also 
penetrating effect of fatty acids is selective of individual 
drug. Out of fatty acid esters, isopropyl palmitate is 
popular. 
Recent trend is towards use of semisynthetic oils that are 
more stable than their natural counterparts. Poorly aqueous 
soluble drugs need to have solubility in dispersed oil phase 
to form efficient o/w microemulsion system. Even with 
increase in oil content in o/w microemulsions leads to 
increase in droplet size. Excipients that are commonly  used 
as oil phase in transdermal formulat ions is isopropyl 
palmitate, isostearylic isostearate, ethyl oleate and alcohols 
such as octanol, decanol and benzyl alcohol
10
. 
Surfactant  
Surfactants are the molecules which when present in low 
concentration will adsorb to the surface of interfaces of a 
system and alter the interfacial energies of the system. The 
interfacial energy is the work required to create unit area 
of an interface. The actual purpose of surfactant is to lower 
the interfacial tension to negligible value facilitating the 
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process of dispersion during preparation of microemulsion. 
It presents the microemulsion with pertinent lipophilic 
character to furnish accurate curvature. This adsorption 
behavior can be attributed to solvent nature and to the 
chemical nature of surfactant that combines both polar and 
non polar group in a single molecule. Due to their dual 
nature these amphiphiles “sit” at interfaces so that their 
hydrophobic moiety is repelled from strong solvent 
interactions. Surfactant screening can be done with help of 
HLB (Hydrophilic lipophilic balance) value. The HLB 
provides a numerical value that suggests whether o/w or 
w/o emulsion will form. It relates molecular structure to 
interfacial packing and film curvature
11
. The HLB concept 
was introduced by GRIFFIN. The accepted fact is that 
generally low HLB surfactants are favorable for w/o 
microemulsion and high HLB surfactants are suited best 
for o/w microemulsions. Surfactants with HLB greater 
than 20 require co-surfactants in order to reduce the HLB 
value within the range entailed by microemulsion to form. 
Table1: Showing HLB ranges and the typical application 
of surfactant related to it 
HLB Value Application 
1- 3.5  Antifoams  
3.5- 8  Water in oil emulsion 
7 -9  Wetting and spreading agents 
8 – 16  Oil in water emulsions 
13 – 16  Detergents 
15 – 40  Solubilizers 
 
Skin permeation enhancement is magnificent function of 
surfactants and the magnitude of permeation enhancement 
is largely dependent on physicochemical properties and 
nature of vehicle
13
. Non ionic surfactants are good 
replacement for naturally occurring surfactants. Tweens 
have been investigated for their min imal toxicity. 
Surfactants such as sorbitan fatty acid esters, polysorbates, 
pegylated fatty alcohols and poloxamers are recurrently 
used. Microemusions are highly dynamic structures, it is 
plausible that monomer surfactants can diffuse to the skin 
surface and act as enhancers facilitating diffusion through 
barrier phase or by increasing the solubility of drug in the 
skin
11,12
. 
Co-surfactants 
In most of the cases, single chain surfactants alone are 
incapable to reduce o/w interfacial tension sufficiently to 
form microemulsion. Owing to its amphiphilic nature, a  
co-surfactant accumulates substantially at interface layer, 
increasing the fluidity of interfacial film by penetrating 
into surfactant layer. Short to medium chain length 
alcohols are generally added as co-surfactants helping in to 
increase the fluidity of interface
12
. Amongst short chain 
alkanols, ethanol is widely used as permeation enhancer. 
In medium chain alcohols 1- butanol was reported to be 
most effective enhancer. The surfactant and co-surfactant 
ratio is a key factor for phase properties. 
Aqueous phase 
Most commonly, water is used as aqueous phase. The pH 
of aqueous phase always needs to be adjusted due to its 
considerable impact on phase behavior of 
microemulsions
11,12
. As in case of microemulsions used for 
parenteral administration aqueous phase should be 
isoosmotic to blood which is adjusted by sodium chloride, 
glycerol, dext rose and sorbitol.  
PHAS E BEHAVIOUR 
The relationship between the phase behavior of mixture 
and its composition can be confined with the support of 
phase diagram. The phase behavior of simple 
microemulsion systems comprising oil, surfactant and co-
surfactant can be studied with the aid of ternary phase 
diagrams in which each corner of the diagram represents 
100% of the met iculous component
14
. However, almost 
always in case of microemulsions, they contain an 
additional component as cosurfactant and/or drug. In the 
case where four or more components are involved, 
pseudoternary diagrams are constructed where a corner 
represents binary mixture of two components as 
surfactant/co-surfactant, water/drug or oil/drug.  
 
Figure 1: This represents a pseudoternary phase diagram 
Phase rule: The phase rule enables identificat ion of the 
number of variables depending on system compositions 
and conditions. It is depicted as  
F = C – P + 2 
Where, F is the number of possible independent changes of 
state or degrees of freedom, C the number of independent 
chemical constituents and P the number of phases present 
in system. The F value determines the system to be 
invariant, monovariant, b ivariant etc depending on its 
value whether zero, 1, 2 or so on. At low surfactant 
concentration, there is series of equilib ria between phases, 
referred as winsor phases  
Winsor I: The microemulsion phase (o/w) is in equilibrium 
with the upper excess oil. The surfactant rich water phase 
coexists with oil phase where surfactant is only present as 
monomers at small concentration.   
Winsor II: The upper microemulsion phase (w/o) is in 
equilibrium with excess of water. The surfactant rich oil 
phase coexists with surfactant poor aqueous phase.  
Winsor III; The middle microemulsion phase (o/w plus 
w/o called bicontinuous) is in equilibrium with excess oil 
and lower excess water. Surfactant rich middle phase 
coexists with both excess water and oil surfactant poor 
phase 
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Winsor IV: Here o il, water and surfactant are 
homogenously are mixed to form isotropic single phase 
micellar solution. 
Inter-conversion between these phases can be produced by 
adjusting the proportions of components. Phase transitions 
are brought by increasing either electrolyte concentration 
in case of ionic surfactants or increasing temperature in 
case of non ionic surfactants
15
. Various investigators have 
explored on interactions in adsorbed interfacial film to 
explain the direction and extent of curvature. Bancroft  
gave a rule stated as “that phase will be external in which  
the emulsifier is most soluble” i.e. oil soluble emulsifiers 
will fo rm w/o emulsion and water soluble emulsifiers will 
form w/o emulsions. The R- ratio was first proposed by 
winsor to account for influence of amphiphiles and 
solvents on interfacial curvature. The R- ratio compares 
tendency for amphiphile to disperse in oil, to its tendency 
to dissolve in water. The R- ratio of cohesive energies 
coming from interaction of interfacial layer with oil , 
divided by energies resulting from interactions of water 
determines the preferred interfacial curvature. A balanced 
interfacial layer is represented by R=1.  
METHOD OF PREPARATION 
Phase titration method:  
Microemulsions are prepared by spontaneous 
emulsification method
16
 which is illustrated with help of 
phase diagrams. Phase diagram construction is practical 
approach to study complex series of interaction which  
occurs when different components are mixed. The aspect 
of the phase diagram is phase eqilibria and demarcat ion of 
phase boundaries. Most often pseudo-ternary phase 
diagrams are constructed to figure out microemulsion zone 
as quaternary phase diagram is time consuming and 
difficult to interpret
14
. 
Phase inversion method:  
Phase inversion of microemulsion happens upon addition 
of excess of dispersed phase. Phase inversion leads to 
radical physical changes as change in particle size that 
alter drug release
16
. During cooling, th is system crosses the 
point of zero spontaneous curvature and minimal surface 
tension, prompting the format ion of finely d ispersed oil 
droplets
17
. Microemulsions can be prepared by controlled 
addition of lower alkanols (butanol, pentanol and hexanol) 
to milky emulsions to produce transparent solutions 
comprising dispersions of either o/w or w/o or colloidal 
dispersions. The lower alkanols are called co-surfactants. 
They lower the interfacial tension between oil and water 
sufficiently low for almost spontaneous format ion. 
Overview of research work on trans dermal drug  
delivery with microemulsion system 
Many studies have been conducted on incorporation of 
various drugs in microemulsion systems. Microemulsions 
based transdermal gel of lacidip ine was formulated and 
characterized for reducing hypertension in rabbits and 
compared with oral suspension of drug
18
.The 
bioavailability as well as permeability was found to be 
increased 3.5 times. Researchers have keenly explored  
potential application, examples of some of which are 
quoted in table 2 
DERMAL DRUG DELIVERY POTENTIAL OF 
TOPICAL MICROEMULS ION FORMULATION  
The considerable amount of work on dermal drug delivery  
has been published during past few years, where attracting 
facet is application of vehicle which has increased the 
attention for pharmaceutical fo rmulat ion
7
. Various 
potentials have been explored in view to describe 
prospective efficacy of microemulsions used cutaneously. 
But, the studies have not been consecutive and moreover 
many studies get confined to in vitro studies, only few put 
upto in vivo studies
33
. This has impeded general 
conclusions between properties of microemulsion and drug 
delivery rate. 
 
Figure 2: The figure represents potential of dermal drug 
delivery of topical microemulsion 
Skin tolerability studies of microemulsions  
It is utmost important point to consider the skin irritation 
and toxico logical reactions which can be the result of 
topical applicat ion of the formulat ion. It was reported that 
the prepared soyabean lecithin microe mulsion (Mygliol 
812N, soybean lecithin, and water) and oleic acid  
microemulsion (Mygliol 812N, soybean lecithin, oleic 
acid, and water) containing ketoprofen and tested skin 
acceptability of these formulat ions along with 
conventional w/o and o/w emulsions  and hydrophilic gel 
on human volunteers
25
. An occlusive patch bearing the 
formulat ion was applied to the upper outer arm for 23 h. 
One hour after removal, skin sites were assessed for signs 
of skin irritation. After assessment, an identical fresh patch 
was applied to the same skin area for a further 23 h. One 
hour after patch removal, skin sites were again assessed. 
The values of scoring assigned were as follows: vesicles, 
5; edema, 4; erythema, 3; flakiness, 2; dryness, 1; 
wrinkling, 1; and glazing, 1. Microemulsion formulations  
showed the highest skin tolerability. Wrinkling (2) and 
glazing (2) were observed with soybean lecithin 
microemulsion, whereas flakiness (1), dryness (1), 
wrinkling (2), and glazing (1) were observed with soybean 
lecithin microemulsion. No edema or erythema was seen. 
The authors concluded that these microemulsions made up 
of biocompatible constituents (high percutaneous effect 
and low human skin  irritation) prompt their use as topical 
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delivery systems both in pharmaceutical and cosmetic 
fields. 
For the skin irritancy test, a single dose of 10 µL of the 
optimized microemulsion (4% oleic acid, 20.5% labrasol, 
20.5% t ranscutol, and 55% water) was applied to the left 
ear of the mouse with the right ear as a control
17
. The 
development of erythema was monitored daily for 6 days. 
The authors concluded that the microemulsion can be 
considered to be safe for the transdermal delivery of 
levobunolol. 
 
Table 2: This represents examples of drugs formulated in microemulsions  
DRUG MICROEMULS ION COMPONENTS   
Ref Oil phase Surfactant/cosurfactant Aqueous phase 
5- Florouracil 
Aceclofenac 
 
Celecoxib  
 
Cyproterone 
Diclofenac  
Estradiol 
 
Flurb iprofen 
Ketoprofen 
Methotrexate 
Nifedipine  
Sucrose 
Tetracaine 
Valdecoxib 
Voriconazole  
IPM 
Labrafil M1944CS 
 
IPM 
 
Eucalyptus oil 
IPM 
Epikuron 200, o leic acid, 
IPM 
 
IPM, ethyl o leate 
Mygliol 812 
Decanol 
Benzyl alcohol 
Ethyl o leate 
IPM 
Oleic acid 
Paraffin, Jojoba 
AOT 
Tween80, span 80, 1,2-octanol, 
cremophor ELP, ethanol 
Caprylic/ capric mono-/  
diglycerides,polysorbate 80 
Brij 30, ethanol 
Lecithin 
Tween 80, span 20/ ethanol, 
isopropanol 
 
Aerosol OT, span 80 
Lecithin, n- butanol 
Lecithin, benzy l alcohol 
Tween 80, taurodeoxycholate 
Labrasol, Plu rol isostearique 
Lecithin, n- propanol 
Labrasol, transcutol 
Tween 80, Brij 97, Glycerol, 
sorbitol 
Water 
Water 
 
Water 
 
Water 
Water 
Water 
 
Water 
Water 
Water, PW 
Water 
Water, 154 mM Nacl 
Water 
Water 
Water 
19 
20 
 
21 
 
22 
23 
24 
 
25 
26 
27 
28 
29 
30 
31 
32 
 
CONCLUS ION 
The skin is evolved to be a defensive barricade. It performs  
this function extraordinarily well and presents, therefore, 
an alarming confrontation to the drug delivery experts. 
Transdermal route of admin istration is perhaps one of the 
most successful controlled release technologies available 
today. Microemulsions are currently the object of 
extensive research worldwide. They represent interesting, 
promising and potential transdermal d rug delivery systems. 
Microemulsion, that are made up of oil, surfactant, co-
surfactant and water have unique properties as drug 
carriers and garnering more attention due to their 
solubilization capacity, transparencies, high stability and 
simplicity in manufacturing. Many in vitro and in vivo 
studies have examined the significance of microemulsions 
by topical and transdermal route.  Microemulsion when  
 
 
applied in the form of gel or liqu id shall obviate this issue 
and will be more acceptable. Concerted research efforts 
directed toward evaluating their systemic and local 
toxicity, as well as their mechanism of action, shall further 
help in ascertaining their efficacy and safety. 
It is important to prudently choose the surfactants and their 
concentration, as a large amount of surfactant is required 
for microemulsion format ion to fulfill the criterion of 
lowering of interfacial tension. More research work is 
required for the production of safe, efficient and more 
compatible microemulsion constituents which will further 
enhance the utility of these novel vehicles. A considerable 
amount of work still needs to be performed to characterize 
the physiochemical behavior of the microemulsions. It 
appears that prospect work will contemplate on the 
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expansion of new and sophisticated analytical tools for the 
microemulsion structure. More organized studies are 
needed for the evaluation of their full potential as they can 
be formed over a wide range of composition. It seems that 
proper selection of the microemulsion components for the 
formulat ion is a key factor in the enhancement of 
transdermal potential. The studies that have been 
conducted so far demonstrate that the microemulsion  
system has terrific potential as a novel transdermal drug 
delivery tool. Based on this review, it could be assumed 
that as a result of these developments, new products based 
on these novel formulations will emerge in the close 
outlook. 
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